| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 375 | 2022 |
| The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration AH Milam, L Rose, AV Cideciyan, MR Barakat, WX Tang, N Gupta, ... Proceedings of the National Academy of Sciences 99 (1), 473-478, 2002 | 261 | 2002 |
| VEGF inhibitors for the treatment of neovascular age-related macular degeneration MR Barakat, PK Kaiser Expert opinion on investigational drugs 18 (5), 637-646, 2009 | 109 | 2009 |
| Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the tanzanite study PA Campochiaro, CC Wykoff, DM Brown, DS Boyer, M Barakat, ... Ophthalmology Retina 2 (4), 320-328, 2018 | 108 | 2018 |
| Safety outcomes of brolucizumab in neovascular age-related macular degeneration: results from the IRIS Registry and Komodo Healthcare Map AM Khanani, MA Zarbin, MR Barakat, TA Albini, PK Kaiser, B Guruprasad, ... JAMA ophthalmology 140 (1), 20-28, 2022 | 104 | 2022 |
| The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study–6 month results AM Khanani, AA Aziz, H Khan, A Gupta, O Mojumder, A Saulebayeva, ... Eye 37 (17), 3574-3581, 2023 | 90 | 2023 |
| Clinicopathologic effects of mutant GUCY2D in Leber congenital amaurosis AH Milam, MR Barakat, N Gupta, L Rose, TS Aleman, MJ Pianta, ... Ophthalmology 110 (3), 549-558, 2003 | 62 | 2003 |
| Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA) RN Khurana, P Merrill, S Yeh, E Suhler, MR Barakat, E Uchiyama, ... British Journal of Ophthalmology 106 (8), 1139-1144, 2022 | 58 | 2022 |
| Suprachoroidal CLS-TA plus intravitreal aflibercept for diabetic macular edema: a randomized, double-masked, parallel-design, controlled study MR Barakat, CC Wykoff, V Gonzalez, A Hu, D Marcus, E Zavaleta, ... Ophthalmology Retina 5 (1), 60-70, 2021 | 47 | 2021 |
| Faricimab treat-and-extend for diabetic macular edema: Two-year results from the randomized Phase 3 YOSEMITE and RHINE trials TY Wong, Z Haskova, K Asik, CR Baumal, KG Csaky, N Eter, JA Ives, ... Ophthalmology 131 (6), 708-723, 2024 | 41 | 2024 |
| Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA) CR Henry, M Shah, MR Barakat, P Dayani, RC Wang, RN Khurana, ... British Journal of Ophthalmology 106 (6), 802-806, 2022 | 41 | 2022 |
| Frequency of urgent or emergent vitreoretinal surgical procedures in the United States during the COVID-19 pandemic MP Breazzano, AA Nair, JF Arevalo, MR Barakat, AM Berrocal, JS Chang, ... JAMA ophthalmology 139 (4), 456-463, 2021 | 41 | 2021 |
| Clinical characterization of suprachoroidal injection procedure utilizing a microinjector across three retinal disorders C Wan, B Kapik, CC Wykoff, CR Henry, MR Barakat, M Shah, RV Andino, ... Translational Vision Science & Technology 9 (11), 27-27, 2020 | 30 | 2020 |
| Retinal vasculitis or vascular occlusion after brolucizumab for neovascular age-related macular degeneration: a systematic review of real-world evidence CC Wykoff, H Matsumoto, MR Barakat, H Karcher, A Lozama, A Mayhook, ... Retina 43 (7), 1051-1063, 2023 | 22 | 2023 |
| The use of implanted programmable infusion pumps in the management of nonmalignant, chronic low-back pain P Staats, M Whitworth, M Barakat, W Anderson, S Lilienfeld Neuromodulation: Technology at the Neural Interface 10 (4), 376-380, 2007 | 19 | 2007 |
| Effect of niacin on retinal vascular diameter in patients with age-related macular degeneration MR Barakat, TI Metelitsina, JC DuPont, JE Grunwald Current eye research 31 (7-8), 629-634, 2006 | 17 | 2006 |
| Coats' disease, megalopapilla and Cornelia de Lange syndrome MR Barakat, EI Traboulsi, JE Sears Ophthalmic Genetics 30 (2), 106-108, 2009 | 14 | 2009 |
| The DAVIO trial: a phase 1, open-label, dose-escalation study of a single injection of EYP-1901 (vorolanib in Durasert® platform) demonstrating reduced treatment burden in wet … AM Abbey, SS Patel, M Barakat, VS Hershberger, WZ Bridges, ... Investigative Ophthalmology & Visual Science 64 (8), 931-931, 2023 | 13 | 2023 |
| Optical coherence tomography anatomic and temporal biomarkers in uveitic macular edema TA Ciulla, B Kapik, MR Barakat, RN Khurana, QD Nguyen, DS Grewal, ... American journal of ophthalmology 237, 310-324, 2022 | 13 | 2022 |
| Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion … AA Aref, IU Scott, PC VanVeldhuisen, J King, MS Ip, BA Blodi, NL Oden, ... JAMA ophthalmology 139 (12), 1285-1291, 2021 | 11 | 2021 |
